Hims & Hers Health Total Current Liabilities 2020-2024 | HIMS

Hims & Hers Health total current liabilities from 2020 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
  • Hims & Hers Health total current liabilities for the quarter ending June 30, 2024 were $0.109B, a 63.3% increase year-over-year.
  • Hims & Hers Health total current liabilities for 2023 were $0.088B, a 84.54% increase from 2022.
  • Hims & Hers Health total current liabilities for 2022 were $0.048B, a 39.48% decline from 2021.
  • Hims & Hers Health total current liabilities for 2021 were $0.079B, a 420.23% increase from 2020.
Hims & Hers Health Annual Total Current Liabilities
(Millions of US $)
2023 $88
2022 $48
2021 $79
2020 $15
2019 $1
2018 $
Hims & Hers Health Quarterly Total Current Liabilities
(Millions of US $)
2024-06-30 $109
2024-03-31 $93
2023-12-31 $88
2023-09-30 $83
2023-06-30 $67
2023-03-31 $56
2022-12-31 $48
2022-09-30 $67
2022-06-30 $56
2022-03-31 $49
2021-12-31 $79
2021-09-30 $52
2021-06-30 $27
2021-03-31 $20
2020-12-31 $15
2020-09-30 $3
2020-06-30 $1
2020-03-31 $1
2019-12-31
2019-09-30 $1
2019-06-30 $1
Sector Industry Market Cap Revenue
Medical Medical Information Systems $5.988B $0.872B
Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $11.978B 0.00
Inspire Medical Systems (INSP) United States $6.055B 188.82
Axonics (AXNX) United States $3.602B 1762.00
IRhythm Technologies (IRTC) United States $2.783B 0.00
Privia Health (PRVA) United States $2.736B 228.00
Enovis (ENOV) United States $2.646B 17.94
Omnicell (OMCL) United States $2.263B 74.03
Azenta (AZTA) United States $2.242B 127.33
10x Genomics (TXG) United States $1.925B 0.00
Clover Health Investments (CLOV) United States $1.657B 0.00
Schrodinger (SDGR) United States $1.422B 0.00
Phreesia (PHR) United States $1.252B 0.00
Standard BioTools (LAB) United States $0.830B 0.00
Fulgent Genetics (FLGT) United States $0.613B 0.00
Talkspace (TALK) United States $0.586B 0.00
Butterfly Network (BFLY) United States $0.582B 0.00
Definitive Healthcare (DH) United States $0.508B 88.00
Health Catalyst (HCAT) United States $0.506B 0.00
Pulmonx (LUNG) United States $0.298B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.248B 0.00
TruBridge (TBRG) United States $0.214B 62.22
P3 Health Partners (PIII) United States $0.142B 0.00
American Well (AMWL) United States $0.139B 0.00
EUDA Health Holdings (EUDA) Singapore $0.106B 0.00
Future Health ESG (FHLT) United States $0.065B 0.00
HeartBeam (BEAT) United States $0.064B 0.00
111 (YI) China $0.057B 0.00
Zepp Health (ZEPP) China $0.050B 0.00
Outset Medical (OM) United States $0.045B 0.00
SHL Telemedicine (SHLT) Israel $0.042B 0.00
CareCloud (CCLD) United States $0.042B 0.00
Movano (MOVE) United States $0.028B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
MSP Recovery (LIFW) United States $0.018B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.007B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00